beta

ALT

Altimmune Inc.

Alt

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Altimmune Inc is a clinical stage immunotherapeutic biotechnology company. It has two vaccine delivery platforms, RespirVec and Densigen.

Market Cap: 28.8 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.altimmune.com

Shares Outstanding: 15.7 Million

Float: 10.6 Million

Dividend: 0.0 (0.0%)

Beta: 2.444308

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 646 Thousand

Ethical Flags

Animal testing

Longest drawdown: 693 trading days

From: 2017-01-10 To: 2019-10-18

Lowest Point:

Altimmune appoints Will Brown as CFO.

via: SeekingAlpha at 2019-06-12 07:15:24:000

Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...

Altimmune appoints Will Brown as CFO.

via: SeekingAlpha at 2019-06-12 07:15:24:000

Altimmune ( ALT ) announced it has appointed Will Brown as Chief Financial Officer. More news on: Altimmune, Inc., Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-05-05 10.0 1.0 10.0
Data provided by IEX Cloud